CINECA IRIS Institutional Research Information System

ZAGGIA, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2129
EU - Europa 2019
AS - Asia 691
SA - Sud America 112
AF - Africa 60
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2074
IT - Italia 509
CN - Cina 302
DE - Germania 268
FR - Francia 218
SE - Svezia 175
IE - Irlanda 134
UA - Ucraina 117
JP - Giappone 100
FI - Finlandia 93
AT - Austria 88
PL - Polonia 68
GB - Regno Unito 67
KR - Corea 67
BR - Brasile 54
IN - India 53
NL - Olanda 51
ES - Italia 47
CA - Canada 41
SN - Senegal 41
AU - Australia 37
GR - Grecia 36
VN - Vietnam 36
TR - Turchia 33
AR - Argentina 32
RU - Federazione Russa 31
BE - Belgio 22
CH - Svizzera 19
PT - Portogallo 17
TW - Taiwan 15
CO - Colombia 12
IL - Israele 12
MX - Messico 12
HK - Hong Kong 11
DZ - Algeria 10
HR - Croazia 10
CL - Cile 9
IR - Iran 8
RS - Serbia 8
TH - Thailandia 8
HU - Ungheria 7
SA - Arabia Saudita 7
SY - Repubblica araba siriana 7
ID - Indonesia 5
PH - Filippine 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
PE - Perù 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
IQ - Iraq 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SG - Singapore 3
SI - Slovenia 3
ZA - Sudafrica 3
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
NP - Nepal 2
RE - Reunion 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CU - Cuba 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
MT - Malta 1
MU - Mauritius 1
PS - Palestinian Territory 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5052
Salva come PNG Salva come JPEG
Città #
Chandler 280
Beijing 159
Dublin 128
Fairfield 123
Houston 123
Redwood City 111
Wilmington 88
Torino 86
Vienna 85
Woodbridge 83
Nyköping 65
Cambridge 61
Seattle 56
Ann Arbor 55
Ashburn 54
Medford 53
Villeurbanne 52
Warsaw 49
Dearborn 45
Jacksonville 44
Pisa 42
Princeton 41
Würzburg 33
Fremont 27
Milan 26
Tokyo 24
Shanghai 23
Buenos Aires 22
Düsseldorf 22
Dong Ket 21
Amsterdam 20
Paris 20
Bethesda 19
Brescia 17
Brussels 17
Rome 16
Turin 16
São Paulo 15
Chengdu 14
Nanjing 14
Ankara 13
Florence 12
Guangzhou 12
Taipei 12
Athens 11
London 11
Zhengzhou 11
San Diego 10
Dallas 9
Fontenay-sous-bois 9
Lyon 9
Munich 9
Boston 8
Brisbane 8
Canberra 8
Memphis 8
New York 8
Roubaix 8
Santiago 8
Los Angeles 7
Mont-saint-aignan 7
Padova 7
Phoenix 7
Pittsburgh 7
Shenyang 7
Birmingham 6
Boardman 6
Chicago 6
Polska 6
Québec 6
Rochester 6
Schwelm 6
Bogotá 5
Central District 5
Garza García 5
Istanbul 5
Jakarta 5
Moscow 5
Osaka 5
Saint-herblain 5
San Francisco 5
Zülpich 5
Bangalore 4
Belgaum 4
Budapest 4
Buffalo 4
Chongqing 4
Gurgaon 4
Hefei 4
Heidelberg 4
Livorno 4
Madrid 4
New Delhi 4
New Orleans 4
Omaha 4
Palermo 4
Portland 4
Romainville 4
Seoul 4
Sofia 4
Totale 2639
Salva come PNG Salva come JPEG
Nome #
Practical treatment using mitotane for adrenocortical carcinoma. 690
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 560
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 484
Management of adrenal cancer: a 2013 update. 399
Management of adjuvant mitotane therapy following resection of adrenal cancer. 283
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 273
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 193
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 177
Diagnosi e terapia del carcinoma corticosurrenalico 161
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 142
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 95
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 95
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 92
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 91
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 90
A prospective study on adjuvant mitotane 86
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 82
Epidemiology of acromegaly in Italy 81
Carcinoma del cortico surrene: chirurgia open o laparoscopia? 76
Evaluation of Cardiovascular Risk Factors in Patients with Incidentally Discovered Adrenal Adenoma during a Follow-Up Longer Than Five Years. 74
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 70
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 68
LA Nefrectomia in corso di surrenectomia radicale per carcinoma Corticosurrenalico modifica i risultati oncologici? 67
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 66
Mitotane 62
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 62
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 61
Demographic Data, Co-Morbidities, Malignancies and Mortality from the First Large-Scale Italian Study on Acromegaly. 59
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 56
Comparison of 1-mg versus 8-mg dexamethasone suppression test (DST) in patients with clinically inapparent adrenal adenoma 56
Midnight salivary cortisol for diagnosis of subclinical Cushing’s syndrome in patients with clinically inapparent adrenocortical adenoma. 56
Pitfalls in the diagnosis of adrenocortical tumors: A lesson from 300 consultation cases 52
THE ROLE OF SURGERY IN THE MANAGEMENT OF RECURRENT ADRENOCORTICAL CARCINOMA: RESULTS OF A RETROSPECTIVE STUDY 49
Rapporto tra acromegalia e neoplasia: fantasia o realtà? 49
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? 48
Mitotane treatment for adrenocortical carcinoma: an overview. 47
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 46
null 40
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer 17
Totale 5255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7936
article - articoli 0
book - libri 0
conference - conferenze 2790
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201851 0000 00 00 00051
2018/2019839 72554631 3955 5385 5195153104
2019/2020920 83626886 51133 9577 90795343
2020/2021684 75505342 6466 7538 44744657
2021/2022657 27322562 5224 4742 2667151102
2022/2023865 908527111 64195 5966 9515571
Totale 5255